In the News

Updates on Cleerly in the News

Cleerly is aware of the lawsuit filed by Heartflow. We are confident in our extensive and well-established intellectual property portfolio and the originality of our technology.

Cleerly has published landmark clinical science that has redefined how cardiovascular disease is understood and treated, which has formed the basis of our novel technologies that provide physicians with actionable insights into their patients’ heart health.

Cleerly was founded on a mission to create a world without heart attacks, and we have never been more focused in our mission and committed to the patients and physicians who count on us.

For any questions, please reach out to press@cleerlyhealth.com

1 min read

Let’s Talk Medtech & CLEERLY

It’s American Heart Month, and Cleerly, a startup that uses artificial intelligence to change the way we diagnose cardiovascular disease is keeping...

Read More

1 min read

Cleerly named to Fierce Medtech's 2021 Fierce 15

In one way or another, the Fierce 15 has always been about celebrating those who are finding new ways of doing things, whether it’s innovators...

Read More

1 min read

Dicardiology: Cleerly Takes Precision Heart Care to the Next Level

Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease. Read on to see more from the article by Dicardiology....

Read More